Based in Abingdon (UK) and Philadelphia (USA) we're a privately owned biotechnology company developing innovative biological therapeutics for the treatment of a range of serious diseases. Our world-leading T cell receptor technology exploits the power of the body’s own immune system to find and kill diseased cells.

We've established a robust technology platform which combines monoclonal T cell receptor (mTCR) targeting technology with an effector technology, anti-CD3 scFv, that catalyses the killing of the targeted diseased cells by the host’s own non-specific cytotoxic T cells. And we're developing a portfolio of products from the platform, called ImmTACs, for the treatment of cancer, chronic infectious disease and diabetes.

Current Job Openings at Immunocore

Business Support

Clinical Development

QMS Administrator
Immunocore, UK